Copyright Nasdaq. Minimum 15 minutes delayed.

Investors & Media

Investor FAQs

Show all

Investor FAQs

Dicerna was incorporated in Delaware in October 2006.
Dicerna’s headquarters are located at 87 Cambridgepark Drive, Cambridge, MA 02140. The main telephone number is (617) 621-8097.
Dicerna’s stock is traded on the NASDAQ Global Market under the symbol DRNA. The company’s initial public offering (IPO) was on January 29, 2014.
Dicerna’s transfer agent is: American Stock Transfer & Trust, LLC.
6201 15th Avenue
Brooklyn, NY 11219
Shareholder Services: (800) 937-5449
 
If your shares are held in your name, you must contact our transfer agent, American Stock Transfer & Trust, LLC. If your shares are held in street name, you must contact your broker to update your address.
Dicerna’s fiscal year ends on December 31st.
Dicerna’s legal counsel is: O’Melveny & Myers LLP
2765 Sand Hill Road
Menlo Park, California 94025
Telephone: (650) 473-2600   Dicerna’s independent auditor is: Deloitte & Touche LLP
200 Berkeley St #400
Boston, MA 02116